Bio-Rad to Buy AbD Serotec – Analyst Blog
Posted on December 17, 2012 at 12:00 PM EST
Bio-Rad discloses deal to acquire AbD Serotec, a division of MorphoSys AG for a cash payment of about $70 million (Euro 53 million).
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here